Siebe Loontiens

Gent, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

Atypical Lentiginous Melanocytic Proliferations Case Series: Relationship to Type II Dysplastic Nevi and Lentiginous Melanoma.

Atypical Lentiginous Melanocytic Proliferations Case Series: Relationship to Type II Dysplastic Nevi and Lentiginous Melanoma.

Journal: Journal of cutaneous pathology
Published: May 25, 2026

Unmasking NF1 mosaicism: optical genome mapping identifies a novel t(15;17) translocation in melanocytes.

Unmasking NF1 mosaicism: optical genome mapping identifies a novel t(15;17) translocation in melanocytes.

Journal: Journal of medical genetics
Published: January 23, 2026

FOS and FOSB Immunohistochemistry and Molecular Testing Reveal Novel Patterns in Proliferative Fasciitis and Myositis, FOSB Rearrangement in Proliferative Funiculitis, and FOSL1 :: RELA Fusion in Pediatric Proliferative Fasciitis.

FOS and FOSB Immunohistochemistry and Molecular Testing Reveal Novel Patterns in Proliferative Fasciitis and Myositis, FOSB Rearrangement in Proliferative Funiculitis, and FOSL1 :: RELA Fusion in Pediatric Proliferative Fasciitis.

Journal: The American journal of surgical pathology
Published: October 28, 2025

The impact of targeted next-generation DNA sequencing on the diagnostic accuracy of endoscopic ultrasound-guided tissue sampling of focal pancreatic lesions.

The impact of targeted next-generation DNA sequencing on the diagnostic accuracy of endoscopic ultrasound-guided tissue sampling of focal pancreatic lesions.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: August 25, 2025

Pediatric PLAG1-Rearranged Fibromyxoid Spindle Cell Tumor: An Emerging Distinct Entity or a Fibroblastic ('Non-Lipogenic') Pattern of Lipoblastoma?

Pediatric PLAG1-Rearranged Fibromyxoid Spindle Cell Tumor: An Emerging Distinct Entity or a Fibroblastic ('Non-Lipogenic') Pattern of Lipoblastoma?

Journal: Pathology international
Published: August 12, 2025

A morphomolecular study of 175 'USP6-associated neoplasms': The USP6 fusion partner strongly depends on morphology and location.

A morphomolecular study of 175 'USP6-associated neoplasms': The USP6 fusion partner strongly depends on morphology and location.

Journal: Histopathology
Published: August 05, 2025

Harmonization of Reporting of ALK Genetic Alterations in Neuroblastoma: A SIOPEN Biology Study.

Harmonization of Reporting of ALK Genetic Alterations in Neuroblastoma: A SIOPEN Biology Study.

Journal: The Journal of molecular diagnostics : JMD
Published: April 08, 2025

A challenging case of an epithelioid haemangioma of bone with novel FOS::ANKRD28 gene fusion.

A challenging case of an epithelioid haemangioma of bone with novel FOS::ANKRD28 gene fusion.

Journal: Pathology
Published: March 06, 2025

Atypical spindle cell/pleomorphic lipomatous tumour: a clinicopathologic, immunohistochemical and molecular study of 55 cases, highlighting TP53 gene alterations as a genetic hallmark of atypical pleomorphic lipomatous tumour.

Atypical spindle cell/pleomorphic lipomatous tumour: a clinicopathologic, immunohistochemical and molecular study of 55 cases, highlighting TP53 gene alterations as a genetic hallmark of atypical pleomorphic lipomatous tumour.

Journal: Histopathology
Published: February 19, 2025

A Challenging Case of an Intraosseous Composite Hemangioendothelioma of the Occipital Bone With YAP1::FOXR1 Fusion.

A Challenging Case of an Intraosseous Composite Hemangioendothelioma of the Occipital Bone With YAP1::FOXR1 Fusion.

Journal: Genes, chromosomes & cancer
Published: November 15, 2024

A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer.

A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer.

Journal: NPJ precision oncology
Published: October 23, 2024

MOXD1 is a lineage-specific gene and a tumor suppressor in neuroblastoma.

MOXD1 is a lineage-specific gene and a tumor suppressor in neuroblastoma.

Journal: Science advances
Published: June 21, 2024
Showing 1-12 of 30

Last Updated: 09/26/2026